NO300099B1 - Mono- og bis-alkylamino-antracykliner - Google Patents

Mono- og bis-alkylamino-antracykliner Download PDF

Info

Publication number: NO300099B1
Authority: NO; Norway
Prior art keywords: bis; daunorubicin; formula; chloroethyl; demethoxy
Prior art date: 1991-07-05

Application number

NO940026A

Other languages

English (en)

Norwegian (no)

Other versions

NO940026D0 (no

NO940026L (no

Inventor

Alberto Bargiotti

Michele Caruso

Daniela Faiardi

Antonino Suarato

Nicola Mongelli

Original Assignee

Pharmacia & Upjohn Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-07-05

Filing date

1994-01-04

Publication date

1997-04-07

1994-01-04 Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa

1994-01-04 Publication of NO940026D0 publication Critical patent/NO940026D0/no

1994-02-16 Publication of NO940026L publication Critical patent/NO940026L/no

1997-04-07 Publication of NO300099B1 publication Critical patent/NO300099B1/no

Links

229940045799 anthracyclines and related substance Drugs 0.000 title claims description 19
229960000975 daunorubicin Drugs 0.000 claims description 32
AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims description 31
STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 claims description 31
STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 claims description 28
150000001875 compounds Chemical class 0.000 claims description 23
125000001309 chloro group Chemical group Cl* 0.000 claims description 18
229930182470 glycoside Natural products 0.000 claims description 18
150000002338 glycosides Chemical class 0.000 claims description 18
229910052739 hydrogen Inorganic materials 0.000 claims description 18
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 17
229960004679 doxorubicin Drugs 0.000 claims description 14
239000001257 hydrogen Substances 0.000 claims description 12
150000003839 salts Chemical class 0.000 claims description 8
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 7
229910052736 halogen Chemical group 0.000 claims description 5
150000002367 halogens Chemical group 0.000 claims description 5
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 5
125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 claims description 4
239000000460 chlorine Substances 0.000 claims description 3
229910052801 chlorine Inorganic materials 0.000 claims description 3
239000003085 diluting agent Substances 0.000 claims description 3
239000008194 pharmaceutical composition Substances 0.000 claims description 3
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 51
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 36
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
238000010828 elution Methods 0.000 description 10
238000000034 method Methods 0.000 description 10
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
239000000203 mixture Substances 0.000 description 7
229910052757 nitrogen Inorganic materials 0.000 description 7
239000000741 silica gel Substances 0.000 description 7
229910002027 silica gel Inorganic materials 0.000 description 7
QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 6
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
XDXDZDZNSLXDNA-TZNDIEGXSA-N Idarubicin Chemical compound C1[C@H](N)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2C[C@@](O)(C(C)=O)C1 XDXDZDZNSLXDNA-TZNDIEGXSA-N 0.000 description 6
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
238000000434 field desorption mass spectrometry Methods 0.000 description 6
238000002360 preparation method Methods 0.000 description 6
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
239000002253 acid Substances 0.000 description 5
-1 2-hydroxyethylamino compounds Chemical class 0.000 description 4
XDXDZDZNSLXDNA-UHFFFAOYSA-N Idarubicin Natural products C1C(N)C(O)C(C)OC1OC1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2CC(O)(C(C)=O)C1 XDXDZDZNSLXDNA-UHFFFAOYSA-N 0.000 description 4
229960000908 idarubicin Drugs 0.000 description 4
RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 4
235000012239 silicon dioxide Nutrition 0.000 description 4
239000002904 solvent Substances 0.000 description 4
125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 3
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
239000000010 aprotic solvent Substances 0.000 description 3
239000010779 crude oil Substances 0.000 description 3
125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 3
125000006239 protecting group Chemical group 0.000 description 3
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
RQFUZUMFPRMVDX-UHFFFAOYSA-N 3-Bromo-1-propanol Chemical compound OCCCBr RQFUZUMFPRMVDX-UHFFFAOYSA-N 0.000 description 2
QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 2
101150041968 CDC13 gene Proteins 0.000 description 2
IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
238000010306 acid treatment Methods 0.000 description 2
125000003277 amino group Chemical group 0.000 description 2
125000003118 aryl group Chemical group 0.000 description 2
229910052794 bromium Inorganic materials 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
201000010897 colon adenocarcinoma Diseases 0.000 description 2
208000029742 colonic neoplasm Diseases 0.000 description 2
230000000694 effects Effects 0.000 description 2
239000012458 free base Substances 0.000 description 2
150000002431 hydrogen Chemical class 0.000 description 2
238000002955 isolation Methods 0.000 description 2
208000032839 leukemia Diseases 0.000 description 2
239000003880 polar aprotic solvent Substances 0.000 description 2
238000002601 radiography Methods 0.000 description 2
239000011541 reaction mixture Substances 0.000 description 2
238000003756 stirring Methods 0.000 description 2
YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 2
QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
STQGQHZAVUOBTE-RPDDNNBZSA-N (7s,9s)-9-acetyl-7-[(2r,4s,5r,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 STQGQHZAVUOBTE-RPDDNNBZSA-N 0.000 description 1
VAVHMEQFYYBAPR-ITWZMISCSA-N (e,3r,5s)-7-[4-(4-fluorophenyl)-1-phenyl-2-propan-2-ylpyrrol-3-yl]-3,5-dihydroxyhept-6-enoic acid Chemical compound CC(C)C1=C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)C(C=2C=CC(F)=CC=2)=CN1C1=CC=CC=C1 VAVHMEQFYYBAPR-ITWZMISCSA-N 0.000 description 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
101150065749 Churc1 gene Proteins 0.000 description 1
239000012359 Methanesulfonyl chloride Substances 0.000 description 1
241001529936 Murinae Species 0.000 description 1
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
125000000217 alkyl group Chemical group 0.000 description 1
239000002168 alkylating agent Substances 0.000 description 1
229940100198 alkylating agent Drugs 0.000 description 1
230000029936 alkylation Effects 0.000 description 1
238000005804 alkylation reaction Methods 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
230000000259 anti-tumor effect Effects 0.000 description 1
239000012867 bioactive agent Substances 0.000 description 1
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
210000004027 cell Anatomy 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
229940125890 compound Ia Drugs 0.000 description 1
239000012050 conventional carrier Substances 0.000 description 1
239000013058 crude material Substances 0.000 description 1
239000003480 eluent Substances 0.000 description 1
239000000284 extract Substances 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
229910052740 iodine Inorganic materials 0.000 description 1
239000011630 iodine Substances 0.000 description 1
JFOZKMSJYSPYLN-QHCPKHFHSA-N lifitegrast Chemical compound CS(=O)(=O)C1=CC=CC(C[C@H](NC(=O)C=2C(=C3CCN(CC3=CC=2Cl)C(=O)C=2C=C3OC=CC3=CC=2)Cl)C(O)=O)=C1 JFOZKMSJYSPYLN-QHCPKHFHSA-N 0.000 description 1
125000005647 linker group Chemical group 0.000 description 1
QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
239000012044 organic layer Substances 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
238000000746 purification Methods 0.000 description 1
AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 1
230000035484 reaction time Effects 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
239000007858 starting material Substances 0.000 description 1
150000003512 tertiary amines Chemical class 0.000 description 1
NHGXDBSUJJNIRV-UHFFFAOYSA-M tetrabutylammonium chloride Substances [Cl-].CCCC[N+](CCCC)(CCCC)CCCC NHGXDBSUJJNIRV-UHFFFAOYSA-M 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO940026A 1991-07-05 1994-01-04 Mono- og bis-alkylamino-antracykliner NO300099B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB919114549A GB9114549D0 (en)	1991-07-05	1991-07-05	Mono and bis alkylamino-anthracyclines
PCT/EP1992/001504 WO1993001201A1 (en)	1991-07-05	1992-07-03	Mono and bis alkylamino-anthracyclines

Publications (3)

Publication Number	Publication Date
NO940026D0 NO940026D0 (no)	1994-01-04
NO940026L NO940026L (no)	1994-02-16
NO300099B1 true NO300099B1 (no)	1997-04-07

Family

ID=10697877

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO940026A NO300099B1 (no)	1991-07-05	1994-01-04	Mono- og bis-alkylamino-antracykliner

Country Status (23)

Country	Link
US (1)	US5496808A (cs)
EP (1)	EP0521458B1 (cs)
JP (1)	JP3153552B2 (cs)
KR (1)	KR100235365B1 (cs)
CN (1)	CN1031878C (cs)
AT (1)	ATE134376T1 (cs)
AU (1)	AU661012B2 (cs)
CA (1)	CA2112818C (cs)
CZ (1)	CZ2494A3 (cs)
DE (1)	DE69208400T2 (cs)
FI (1)	FI106204B (cs)
GB (1)	GB9114549D0 (cs)
GR (1)	GR3019429T3 (cs)
HU (1)	HU218913B (cs)
IE (1)	IE76921B1 (cs)
IL (1)	IL102409A (cs)
MX (1)	MX9203928A (cs)
NO (1)	NO300099B1 (cs)
NZ (1)	NZ243450A (cs)
RU (1)	RU2118328C1 (cs)
TW (1)	TW201753B (cs)
WO (1)	WO1993001201A1 (cs)
ZA (1)	ZA924971B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9325420D0 (en) *	1993-12-13	1994-02-16	Erba Carlo Spa	4'-o-sulfonyl-anthracycline derivatives
GB9325417D0 (en) *	1993-12-13	1994-02-16	Erba Carlo Spa	3'- aziridino-anthracycline derivatives
WO1996008265A1 (en) *	1994-09-12	1996-03-21	The Trustees Of The University Of Pennsylvania	Corticotropin release inhibiting factor and methods of using same
ATE176242T1 (de) *	1995-10-16	1999-02-15	Kyowa Hakko Kogyo Kk	Uck14-verbindungen
DE19548474A1 (de) *	1995-12-22	1997-06-26	Wacker Chemie Gmbh	Aliphatisch ungesättigte Reste aufweisende Organopolysiloxane, deren Herstellung und deren Verwendung in vernetzbaren Massen
GB9613433D0 (en) *	1996-06-26	1996-08-28	Pharmacia Spa	Fluoro labelled anthracyclinone and anthracycline derivatives
AU6150498A (en) *	1997-02-07	1998-08-26	Wistar Institute, The	Methods and compositions for the inhibition of interleukin-12 production
GB9806324D0 (en) *	1998-03-24	1998-05-20	Pharmacia & Upjohn Spa	Antitumour synergetic composition
GB9904387D0 (en) *	1999-02-25	1999-04-21	Pharmacia & Upjohn Spa	Antitumour synergistic composition
GB9904386D0 (en)	1999-02-25	1999-04-21	Pharmacia & Upjohn Spa	Antitumour synergistic composition
EP4474386A1 (en) *	2023-06-07	2024-12-11	Academisch Ziekenhuis Leiden h.o.d.n. LUMC	Anthracyclines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU570439B2 (en) *	1983-03-28	1988-03-17	Compression Labs, Inc.	A combined intraframe and interframe transform coding system
US4591637A (en) *	1985-01-17	1986-05-27	Sri International	Open chain-morpholino adriamycins
FR2591599B1 (fr) *	1985-12-17	1988-08-05	Hoechst Lab	Nouvelles anthracyclines et medicaments les contenant
DE3842836A1 (de) *	1988-12-20	1990-06-21	Behringwerke Ag	Rhodomycine mit einer modifizierten kohlenhydrat-einheit

1991
- 1991-07-05 GB GB919114549A patent/GB9114549D0/en active Pending
1992
- 1992-06-26 US US07/904,650 patent/US5496808A/en not_active Expired - Fee Related
- 1992-06-30 DE DE69208400T patent/DE69208400T2/de not_active Expired - Fee Related
- 1992-06-30 EP EP92111054A patent/EP0521458B1/en not_active Expired - Lifetime
- 1992-06-30 AT AT92111054T patent/ATE134376T1/de active
- 1992-07-03 CA CA002112818A patent/CA2112818C/en not_active Expired - Fee Related
- 1992-07-03 RU RU94021658A patent/RU2118328C1/ru active
- 1992-07-03 CZ CZ9424A patent/CZ2494A3/cs unknown
- 1992-07-03 ZA ZA924971A patent/ZA924971B/xx unknown
- 1992-07-03 HU HU9400022A patent/HU218913B/hu not_active IP Right Cessation
- 1992-07-03 IE IE922177A patent/IE76921B1/en not_active IP Right Cessation
- 1992-07-03 KR KR1019940700015A patent/KR100235365B1/ko not_active Expired - Fee Related
- 1992-07-03 IL IL10240992A patent/IL102409A/en not_active IP Right Cessation
- 1992-07-03 WO PCT/EP1992/001504 patent/WO1993001201A1/en not_active Ceased
- 1992-07-03 AU AU22294/92A patent/AU661012B2/en not_active Ceased
- 1992-07-03 JP JP50195893A patent/JP3153552B2/ja not_active Expired - Fee Related
- 1992-07-03 MX MX9203928A patent/MX9203928A/es not_active IP Right Cessation
- 1992-07-04 TW TW081105323A patent/TW201753B/zh active
- 1992-07-04 CN CN92108867A patent/CN1031878C/zh not_active Expired - Fee Related
- 1992-07-06 NZ NZ243450A patent/NZ243450A/en unknown
1994
- 1994-01-03 FI FI940011A patent/FI106204B/fi active
- 1994-01-04 NO NO940026A patent/NO300099B1/no not_active IP Right Cessation
1996
- 1996-03-27 GR GR960400814T patent/GR3019429T3/el unknown

Also Published As

Publication number	Publication date
FI940011A7 (fi)	1994-01-03
HK1006460A1 (en)	1999-02-26
KR100235365B1 (ko)	1999-12-15
EP0521458B1 (en)	1996-02-21
IE922177A1 (en)	1993-01-13
AU2229492A (en)	1993-02-11
NO940026D0 (no)	1994-01-04
CA2112818A1 (en)	1993-01-21
CA2112818C (en)	2003-02-04
IE76921B1 (en)	1997-11-05
CN1031878C (zh)	1996-05-29
WO1993001201A1 (en)	1993-01-21
GB9114549D0 (en)	1991-08-21
TW201753B (cs)	1993-03-11
NO940026L (no)	1994-02-16
HU218913B (hu)	2000-12-28
JP3153552B2 (ja)	2001-04-09
NZ243450A (en)	1993-11-25
HU9400022D0 (en)	1994-05-30
AU661012B2 (en)	1995-07-13
US5496808A (en)	1996-03-05
JPH06508841A (ja)	1994-10-06
DE69208400D1 (de)	1996-03-28
ATE134376T1 (de)	1996-03-15
CN1069981A (zh)	1993-03-17
RU2118328C1 (ru)	1998-08-27
EP0521458A1 (en)	1993-01-07
MX9203928A (es)	1993-04-01
FI940011A0 (fi)	1994-01-03
CZ2494A3 (en)	1994-07-13
GR3019429T3 (en)	1996-06-30
IL102409A (en)	1995-12-08
FI106204B (fi)	2000-12-15
HUT70480A (en)	1995-10-30
DE69208400T2 (de)	1996-06-27
IL102409A0 (en)	1993-01-14
ZA924971B (en)	1993-03-31

Legal Events

Date	Code	Title	Description
2003-03-10	MM1K	Lapsed by not paying the annual fees	Free format text: LAPSED IN JANUARY 2003

Publication	Publication Date	Title
US4672057A (en)	1987-06-09	Morpholino derivatives of daunorubicin and doxorubicin
NO300099B1 (no)	1997-04-07	Mono- og bis-alkylamino-antracykliner
CZ279676B6 (cs)	1995-06-14	Způsob výroby 4´-deoxydaunorubicinu a 4´-deoxydoxorubicinu
US4366149A (en)	1982-12-28	Antitumor anthracycline glycosides, their preparation, intermediates therefor, and compositions and use thereof
EP0434960B1 (en)	1996-09-18	Chiral 1,5-diiodo-2-methoxy or benzyloxy intermediates
IE53120B1 (en)	1988-07-06	Anthracyclines
DK169076B1 (da)	1994-08-08	Anthracyclinglycosider, fremgangsmåder til deres fremstilling samt farmaceutiske præparater indeholdende glycosiderne
US5532218A (en)	1996-07-02	3'-aziridino-anthracycline derivatives
EP0024727B1 (en)	1982-05-26	Anthracycline glycosides, processes for their preparation and pharmaceutical composition containing them
CS202570B2 (en)	1981-01-30	Process for preparing aminoglycsidic antibiotics
US4125710A (en)	1978-11-14	Method for preparing auranofin
JPS632271B2 (cs)	1988-01-18
EP0475071A1 (en)	1992-03-18	2-acyloxy-4-morpholinyl anthracycline
RU2043360C1 (ru)	1995-09-10	Антрациклин гликозиды или их фармацевтически приемлемые соли, обладающие противоопухолевыми свойствами, и способ их получения
CA1075685A (en)	1980-04-15	Process for the synthesis of 3',4'-dideoxykanamycin b
EP0683787B1 (en)	1997-09-10	4'-o-sulfonyl-anthracycline derivatives
Rosenbrook Jr et al.	1975	SPECTINOMYCIN MODIFICATION. II 7-EPI-SPECTINOMYCIN
HK1006460B (en)	1999-02-26	Mono and bis alkylamino-anthracyclines
PT97663B (pt)	1998-09-30	Processo de preparacao de 3'-desamino-4'-desoxi-4'-amino-8-fluoro-antraciclinas, de composicoes farmaceuticas que as contem e de seus intermediarios
US4889926A (en)	1989-12-26	Method for the synthesis of (2"R)-4'-O-tetra-hydropyranyladriamycim using 14-chloro-daunomycin as an intermediate
US4276289A (en)	1981-06-30	Antitumor glycosides, their preparation and use
NO314148B1 (no)	2003-02-03	13-dihydro-3'aziridino-antracykliner, fremgangsmåte for fremstilling av samme og farmasöytisk sammensetning inneholdende samme
CS235540B2 (cs)	1985-05-15	Způsob výroby nových derivátů glykosidů anthracyklinu
IE44208B1 (en)	1981-09-09	New process for the synthesis of 3',4'-dideoxykanamycin b